LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 103 of 166
Next
>>
>
2551 to 2575 of 4140 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Timepoint	Timepoint Unit	Mean Total Cell Count Before Treatment	Mean Total Cell Count After Treatment	Mean Total Control Cell Count	Mean Relative Cell Count	Mean Normalized Growth Rate Inhibition Value
BT-20	GSK 690693	0.04	uM	LJP5	72	hr	1657	4744	5588	0.8493	0.8218
BT-20	GSK 690693	0.12	uM	LJP5	72	hr	1657	4599	5588	0.8232	0.7890
BT-20	GSK 690693	0.37	uM	LJP5	72	hr	1657	4300	5588	0.7694	0.7219
BT-20	GSK 690693	1.11	uM	LJP5	72	hr	1657	3817	5588	0.6833	0.6093
BT-20	GSK 690693	3.33	uM	LJP5	72	hr	1657	3450	5588	0.6175	0.5187
BT-20	GSK 690693	10	uM	LJP5	72	hr	1657	3072	5588	0.5500	0.4220
BT-20	SNS-032	0.04	uM	LJP6	72	hr	1657	4651	5383	0.8645	0.8359
BT-20	SNS-032	0.12	uM	LJP6	72	hr	1657	1617	5383	0.3006	-0.0143
BT-20	SNS-032	0.37	uM	LJP6	72	hr	1657	1197	5383	0.2226	-0.1742
BT-20	SNS-032	1.11	uM	LJP6	72	hr	1657	1048	5383	0.1950	-0.2366
BT-20	SNS-032	3.33	uM	LJP6	72	hr	1657	1037	5383	0.1925	-0.2425
BT-20	SNS-032	10	uM	LJP6	72	hr	1657	1155	5383	0.2147	-0.1917
BT-20	Afatinib	0.04	uM	LJP6	72	hr	1657	3980	5383	0.7400	0.6753
BT-20	Afatinib	0.12	uM	LJP6	72	hr	1657	4514	5383	0.8387	0.8034
BT-20	Afatinib	0.37	uM	LJP6	72	hr	1657	4690	5383	0.8712	0.8428
BT-20	Afatinib	1.11	uM	LJP6	72	hr	1657	5087	5383	0.9459	0.9359
BT-20	Afatinib	3.33	uM	LJP6	72	hr	1657	4854	5383	0.9034	0.8832
BT-20	Afatinib	10	uM	LJP6	72	hr	1657	1569	5383	0.2917	-0.0317
BT-20	GSK1904529A	0.04	uM	LJP6	72	hr	1657	4830	5383	0.8982	0.8776
BT-20	GSK1904529A	0.12	uM	LJP6	72	hr	1657	4877	5383	0.9056	0.8860
BT-20	GSK1904529A	0.37	uM	LJP6	72	hr	1657	5067	5383	0.9418	0.9307
BT-20	GSK1904529A	1.11	uM	LJP6	72	hr	1657	5222	5383	0.9705	0.9654
BT-20	GSK1904529A	3.33	uM	LJP6	72	hr	1657	5204	5383	0.9668	0.9607
BT-20	GSK1904529A	10	uM	LJP6	72	hr	1657	5435	5383	1.0102	1.0125
BT-20	Linsitinib	0.04	uM	LJP5	72	hr	1657	4776	5588	0.8550	0.8287

|<
<<
Previous
Page 103 of 166
Next
>>
>
2551 to 2575 of 4140 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)